Summary -A new market study, titled “Global Q Fever Market Size, Status and Forecast 2020-2026” has been featured on WiseGuy Reports.
Introduction
Q fever is a mild disease with flu-like symptoms. In Q fever, the infection is caused by the bacterium Coxiella burnetii. Many patients have no symptoms at all, while, in some cases, the infection could reoccur/resurface years later. Chronic Q fever may damage the heart, liver, brain, lungs, and could cause diabetes in some cases.
The major factors driving the growth of the market include rising prevalence of Q fever coupled with increasing Q fever hospitalization rates, rising worldwide cattle, sheep, and goat population, growth in risk factors of Q fever, and globally growing geriatric population.
The global Q fever market has been segmented on the basis of type, diagnosis, treatment, end user, and region.
The global Q fever market, by type, has been segmented into acute and chronic.
The global Q fever market, by diagnosis, has been segmented into serology tests and others.
The global Q fever market, by treatment, has been segmented into antibiotics and surgery.
The global Q fever market, by end user, has been segmented into patients, hospitals and clinics, and others.
ALSO READ https://www.marketwatch.com/press-release/q-fever-industry---treatm...

The global Q fever market is expected to reach a market value of USD 9,850.65 million by 2023 from USD 6,249.68 million in 2017 and is expected to register a CAGR of 7.83% during the forecast period of 2018 to 2023. In 2017, Asia-Pacific held the highest share of the market at 44.9%, followed by the Middle East and Africa with a share of 25.4%.
Key Players
Merck KGaA, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Basilea Pharmaceutica Ltd, Sanofi S. A., Melinta Therapeutics, Inc., Bayer AG, Johnson & Johnson Services, Inc., Yashica Pharmaceuticals, and AtoxBio.
Study Objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Q fever market
• To provide insights into factors affecting the market growth
• To analyze the global Q fever market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by type, diagnosis, treatment, end user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Q fever market
Target Audience
• Hospitals
• Q fever Companies
• Associations and Organizations
Key Findings
• The global Q fever market is expected to reach USD 9,850.65 million by 2023 at a CAGR of 7.83% from 2018 to 2023
• On the basis of type, the chronic segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.33% during the forecast period
• On the basis of diagnosis, the serology tests segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.32% during the forecast period
• On the basis of treatment, the antibiotics segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 7.32% during the forecast period
• On the basis of end user, the patients segment accounted for the largest market share in 2017 and is expected to grow at a CAGR of 8.21% during the forecast period
Regional Analysis
• Americas
o North America
US
Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o UAE
o Saudi Arabia
o Oman
o Kuwait
o Qatar
o Africa
o Rest of the Middle East & Africa
FOR MORE DETAILS https://www.wiseguyreports.com/reports/4255640-global-q-fever-marke...

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
sales@WiseGuy Reports.com
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)